Glucocorticoid metabolism in the human fetal lung: Implications for lung development and the pulmonary surfactant system

被引:48
作者
Garbrecht, MR
Klein, JM
Schmidt, TJ
Snyder, JM
机构
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA
来源
BIOLOGY OF THE NEONATE | 2006年 / 89卷 / 02期
关键词
glucocorticoid metabolism; human fetal lung; human fetal lung maturation; pulmonary surfactant production; 11 beta-hydroxysteroid dehydrogenase;
D O I
10.1159/000088653
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
It has been nearly 35 years since Liggins and Howie first reported the benefits of antenatal glucocorticoid (GC) treatment to promote the maturation of the human fetal lung, and nearly that long since Pasqualini and colleagues demonstrated that the human fetal lung actively metabolizes GCs. Since that time, our understanding of the effects of GCs on fetal lung maturation and pulmonary surfactant production has increased dramatically. Similarly, characterization of the enzymes involved in GC metabolism has greatly expanded our understanding of GC signaling in target tissues. In man, the biologically active GC ( cortisol) and the biologically inactive GC ( cortisone) are interconverted by the tissue-specific expression of the type 1 and type 2 11 beta-hydroxysteroid dehydrogenase enzymes (HSD1 and HSD2). Much of the research on GC metabolism in peripheral target tissues has focused on the role of HSD1 in amplifying the effects of GCs in liver and adipose tissue or on the role of HSD2 in blocking the effects of GCs in the kidney and placenta. In contrast, the role of GC metabolism in modulating the effects of GCs on fetal lung maturation and the pulmonary surfactant system in humans is less understood. The goal of this review article is to present a brief overview of the role of GCs in human fetal lung maturation and pulmonary surfactant production, and to familiarize the reader with the biochemistry of the metabolism of natural and synthetic GCs by the HSD enzymes. In addition, we will review data concerning the expression and activity of the HSD enzymes in the human fetal lung and contrast this to what is known about the HSD enzymes in the fetal rodent lung. Although rodents, rabbits, sheep, and several primates have been invaluable model systems for the study of fetal lung development, we have chosen to largely focus this review on human lung, since there are significant differences in GC metabolism between humans and other species. Copyright (C) 2006 S. Karger AG, Basel.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 119 条
[1]   CORTISOL-CORTISONE INTERCONVERSION IN HUMAN-FETAL LUNG - CONTRASTING RESULTS USING EXPLANT AND MONOLAYER-CULTURES SUGGEST THAT 11-BETA-HYDROXYSTEROID DEHYDROGENASE (EC 1.1.1.146) COMPRISES 2 ENZYMES [J].
ABRAMOVITZ, M ;
BRANCHAUD, CL ;
MURPHY, BEP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (03) :563-568
[2]   INVESTIGATION OF FACTORS INFLUENCING 11-BETA-HYDROXYSTEROID DEHYDROGENASE (EC 1.1.1.146) ACTIVITY IN MIDGESTATIONAL HUMAN-FETAL LUNG MONOLAYER AND EXPLANT CULTURES [J].
ABRAMOVITZ, M ;
CARRIERO, R ;
MURPHY, BEP .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 21 (06) :677-683
[3]   GENE STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN HSD11K GENE ENCODING THE KIDNEY (TYPE-2) ISOZYME OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
AGARWAL, AK ;
ROGERSON, FM ;
MUNE, T ;
WHITE, PC .
GENOMICS, 1995, 29 (01) :195-199
[4]  
ALCORN D, 1977, J ANAT, V123, P649
[5]   Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease [J].
André, B ;
Thébaud, B ;
Odièvre, MH ;
Razafimahefa, H ;
Zupan, V ;
Dehan, M ;
Lacaze-Masmonteil, T .
INTENSIVE CARE MEDICINE, 2000, 26 (10) :1496-1500
[6]   SURFACTANT APOPROTEIN-A (SP-A) IS SYNTHESIZED IN AIRWAY CELLS [J].
AUTEN, RL ;
WATKINS, RH ;
SHAPIRO, DL ;
HOROWITZ, S .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (05) :491-496
[7]  
Ballard PL, 2000, CONT ENDOCRINOL, P1
[8]   Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids [J].
Ballard, PL ;
Ertsey, R ;
Gonzales, LW ;
Gonzales, J .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (06) :599-607
[9]   Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells [J].
Bandi, N ;
Kompella, UB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 425 (02) :109-116
[10]   Multiple courses of antenatal corticosteroids and outcome of premature neonates [J].
Banks, BA ;
Cnaan, A ;
Morgan, MA ;
Parer, JT ;
Merrill, JD ;
Ballard, PL ;
Ballard, RA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (03) :709-717